However, several studies have reported that METTL3, instead of METTL14, is upregulated in BCa, indicating that m6A is a dynamic modification and that the dominant m6A enzyme may vary in different stages of tumour progression 35, 36. The gene discussed is METTL3; the disease is neoplasm.